CD6 and inflammatory bowel disease: Regarding the appearance of extra-intestinal manifestations, logistic regression analyses showed a significant association of homo- or heterozygous combinations of the CD6 rs17824933G allele with lower risk of ankylosing spondylitis in the whole cohort of IBD patients (Table 5).